New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export PFE’s income statement to Excel — free account
Pfizer Inc.
PFEHealthcare Drug Manufacturers General
Pfizer Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.6 billion, down 1.65% from fiscal 2024.
- Revenue
- −0.43%
- EPS
- −9.68%
- Free cash flow
- +20.0%
- Total debt
- +1.55%
Quarter to September 2026, against a year earlier
27.68
0.11
+0.40%
Follow PFE
Alert me
Pfizer Inc. 8-K filed Nov 3, 2026
5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
Red flags
-
Officer departure
Pfizer Inc. reported the departure of an officer or director